Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2011-004787-30-DE
EUCTR2011-004787-30-DE
Active, not recruiting
Phase 1

Modification of the visual outcome after optic neuritis in CIS or MS by Gilenya® - MOVING

Charite Universitaetsmedizin Berlin0 sites88 target enrollmentJuly 13, 2012
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsGilenya®Extavia®

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Charite Universitaetsmedizin Berlin
Enrollment
88
Status
Active, not recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 13, 2012
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Charite Universitaetsmedizin Berlin

Eligibility Criteria

Inclusion Criteria

  • •relapsing\-remitting Multiple sclerosis (MS) or clinically isolated syndrom
  • •Informed consent
  • •First acute optic neuritis (ON) bout on qualifying eye within 30 days bevore screening
  • •Age 18 \- 55 years at screening
  • •EDSS \= 6,0
  • •No MS bout except ON in the last 30 days before secreening
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 88

Exclusion Criteria

  • •Know contraindications againts therapy with Fingolimod (Gilenya®) or Interferon beta\-1b Extavia®
  • •pregnancy or lactation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Visual disturbances and neurological changes after stays in space - a study of possible countermeasuresMuscular atrophy, bone loss, deconditioning of the cardiovascular system, deterioration of the vestibular system, deterioration of cognitive performance, fluid shifts, eye changes, SANS
DRKS00030848DLR- Deutsches Zentrum für Luft- und Raumfahrt / Institut für Luft- Und Raumfahrtmedizin24
Not yet recruiting
Not Applicable
Visual disturbances of patients following operatioHealth Condition 1: O- Medical and Surgical
CTRI/2023/03/050562GCS medical college and hospital
Recruiting
Not Applicable
The changes in visual function after intravitreal bevacizmab for ocular neovascular diseasesOcular neovascular diseases
JPRN-UMIN000021074Ophthalmology, Kagoshima university50
Completed
Not Applicable
Patient satisfaction and quality of vision following implantation of latest technology based Intraocular Lens implantation after cataract surgery in both eyes
CTRI/2020/08/027105Dr Sri Ganesh30
Recruiting
Not Applicable
Visual field changes after vitrectomy for macular diseasesmacular hole, epiretinal membrane
JPRN-UMIN000035354Kanazawa University150